Final Insights on Current Bladder Cancer Clinical Trials

Neal Shore, MD, FACS, shares his final thoughts on the current landscape of clinical trials for both non-muscle-invasive bladder cancer and muscle-invasive bladder cancer, providing insights into the potential impact and future directions of these studies.

EP: 1.Comparing Long-Term Efficacy of Bladder-Preserving Therapies for NMIBC

EP: 2.SunRISe-1: Examining Combination Therapy for HR NMIBC

EP: 3.NURE-COMBO: Patient Population, Regimen, and Efficacy in MIBC

EP: 4.Novel Therapy + 5-Year Bladder Preservation for Patients with NMIBC

EP: 5.SunRISe-1 and NURE-COMBO: Addressing Unmet Needs and Expanding Treatment Options for Bladder Cancer

EP: 6.Novel Therapies for Bladder Cancer: Safety Profiles and Study Design Considerations

Now Viewing

EP: 7.Final Insights on Current Bladder Cancer Clinical Trials

Video content above is prompted by the following question(s):

• Based on the data presented, how might these novel therapeutic approaches potentially change the standard of care and clinical management of NMIBC and MIBC in the future?

Related Videos

Related Content

Advertisement

December 26th 2024

ICYMI: Highlights From AMCP Nexus 2024

Kyle Munz

Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.

December 21st 2024

ICYMI: Highlights From ASCO 2024

Pearl Steinzor

Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small cell lung cancer (NSCLC), multiple myeloma, metastatic colorectal cancer (mCRC), and more.

December 18th 2024

ICYMI: Highlights From SLEEP 2024

Kyle Munz

Check out our top 5 most-viewed pieces of coverage from the 2024 SLEEP meeting.

December 12th 2024

ICYMI: Highlights From ACTRIMS 2024

Kyle Munz

Read about the diverse array of research presented at this year's meeting, including novel technological advancements and insights into disease progression in multiple sclerosis (MS).

Related Content

Advertisement

December 26th 2024

ICYMI: Highlights From AMCP Nexus 2024

Kyle Munz

Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.

December 21st 2024

ICYMI: Highlights From ASCO 2024

Pearl Steinzor

Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small cell lung cancer (NSCLC), multiple myeloma, metastatic colorectal cancer (mCRC), and more.

December 18th 2024

ICYMI: Highlights From SLEEP 2024

Kyle Munz

Check out our top 5 most-viewed pieces of coverage from the 2024 SLEEP meeting.

December 12th 2024

ICYMI: Highlights From ACTRIMS 2024

Kyle Munz

Read about the diverse array of research presented at this year's meeting, including novel technological advancements and insights into disease progression in multiple sclerosis (MS).